Skip to content
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
Menu
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
CSE: ABRT • FSE: VB50
CSE: ABRT
ABRT
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
Menu
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
CSE: ABRT • FSE: VB50
CSE: ABRT
ABRT

Press & Updates

Here you will find updates on our work at Albert Labs.
Keep up to date with our progress by following us on social media.
Twitter
Linkedin
Youtube
Instagram
Albert Labs Welcomes Dr. Shabir Hassam to Board of Directors

Corporate Updates

Albert Labs Welcomes Dr. Shabir Hassam to Board of Directors
Albert Labs Management and Board of Director Announcement
Albert Labs Receives preliminary acceptance of 35 Novel Inventive Claims for Patent Protected Manufa
AL EODDP
Albert Labs Announces Private Placement@4x
Ingenu LOI@4x

In the News

Industry News

psychedelic therapy
  • October 22, 2022
  • The Manual

Psychedelic Therapy isn’t Fringe Anymore

Nick Hilden

Industry News

psychedelics cure
  • October 22, 2022
  • NOVA

Can Psychedelics Cure?

Larkin McPhee

Industry News

discrimination in mental health
  • October 22, 2022
  • The Lancet

The Lancet Commission on Ending Stigma and Discrimination in Mental Health

Prof Graham Thornicroft PhD, Charlene Sunkel NSC, et al.

Industry News

Innovation Passport
  • October 12, 2022
  • PSYCH

The MHRA’s Innovation Passport

Industry News

pharmaceutical dependence
  • October 12, 2022
  • Vogue

Can Psilocybin Challenge Our Pharmaceutical Dependence?

Fiorella Valdesolo

Industry News

magic mushroom experience
  • October 10, 2022
  • Monash University

The Magic Mushroom Experience: Taking Psilocybin for Science

Devon Stoliker, Adeel Razi

Innovative mental health medicines for patients with unmet needs

  • Legal Disclaimer
  • Privacy Policy
  • Modern Slavery Statement
  • Cookie Policy
  • Legal Disclaimer
  • Privacy Policy
  • Modern Slavery Statement
  • Cookie Policy

© 2024 Albert Labs. All Rights Reserved

  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
Twitter Linkedin Youtube Envelope
CSE:ABRT
FSE: VB50
CSE:ABRT
FSE: VB50

About Albert Labs

We are a pharmaceutical company leveraging our drug development and clinical research expertise to accelerate the development of highly effective mental health medicines.

If you would like support or more information around making an investment, please contact [email protected]

Twitter Linkedin Youtube Envelope

Complete this form to receive corporate updates and further details on how to invest in Albert Labs. By completing this form, you agree to our privacy policy.

  • This field is for validation purposes and should be left unchanged.
Twitter
Youtube
Linkedin
Instagram
Envelope
Twitter
Youtube
Linkedin
Instagram
Envelope

By completing this form you agree to our privacy policy. You will be sent corporate updates and further details including how to invest in Albert Labs.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok